Decision Making Protocols in Advanced Clinical Case Handling in Theriogenology

1. Introduction

2. Foundational Decision-Making Framework

3. Decision Protocols by Clinical Scenario

3.1 Dystocia Management (Bovine / Equine)

1. Initial assessment (<5 min): Determine stage of labor, duration of straining, fetal presentation (longitudinal/transverse), fetal viability via corneal reflex and withdrawal response.
2. Classification:
   • Fetal origin: Absolute/relative oversize, malpresentation, malposture, malposition, fetal malformation.
   • Maternal origin: Pelvic inadequacy, uterine inertia, uterine torsion, incomplete cervical dilation.
3. Decision node — torsion vs. non-torsion:
   • Uterine torsion confirmed (vaginal wall spiraling, rectal palpation of broad ligaments): Roll technique (Schaffer's method) or surgical correction; if >360°, cesarean section.
   • No torsion: Proceed to assisted delivery or fetotomy decision.
4. Assisted delivery criteria: Fetus alive + birth canal adequate + traction force ≤ two adults with obstetric chains. Maximum traction time: 30 minutes.
5. Fetotomy decision: Fetus dead + birth canal accessible + cow stable → subcutaneous fetotomy (partial or complete).
6. Cesarean section criteria: Live fetus at risk + failed mutation + traction not feasible + bilateral hip lock (bovine) + uterine torsion unresolvable per vaginum.
7. Post-intervention: Oxytocin (20–30 IU IM bovine), broad-spectrum antibiotics (penicillin/ampicillin), NSAID (flunixin meglumine 2.2 mg/kg), uterine lavage if contamination suspected, monitor for retained fetal membranes (RFM).

3.2 Repeat Breeder Syndrome (Bovine)

1. Rule out infectious causes: Endometrial cytology (PMN% >18% = endometritis), uterine culture (Trueperella pyogenes, Histophilus somni, Ureaplasma), Campylobacter fetus PCR, BVDV/IBR serology.
2. Evaluate semen quality: Computer-assisted semen analysis (CASA) — motility >70%, morphology >70% normal forms, concentration ≥500×10⁶/mL straw.
3. Evaluate fertilization failure vs. early embryonic death (EED):
   • Progesterone assay on Day 5–7 post-AI: Low P4 = anovulation or short luteal phase → GnRH at AI + PGF₂α protocol.
   • Ultrasound on Day 7–14: Embryo present but regressing = EED → HCG or GnRH on Day 5 to support luteal phase.
4. Ovsynch protocol for non-detected estrus: GnRH (Day 0) → PGF₂α (Day 7) → GnRH (Day 9) → FTAI (Day 10).
5. Endometritis treatment: Intrauterine cephapirin benzathine (500 mg) or systemic oxytetracycline; prostaglandin F₂α if CL present (luteolysis + uterine contractility).

3.3 Pyometra

1. Confirm CL presence via transrectal ultrasound (hyperechoic structure on ovary with fluid-filled uterus).
2. Species-specific approach:
   • Bovine: PGF₂α (25 mg dinoprost or 500 µg cloprostenol IM) → luteolysis → cervical relaxation → uterine evacuation. Resolution rate ~80% with single dose; re-treat at 14 days if CL persists.
   • Canine: Open pyometra → stabilize (IV fluids, antibiotics) → ovariohysterectomy (OHE) is definitive. Medical management (aglepristone + misoprostol) reserved for breeding bitches.
   • Feline: OHE preferred; medical management risk is high due to uterine fragility.
3. Closed pyometra decision: Surgical emergency regardless of species — risk of uterine rupture and septic peritonitis mandates immediate surgical referral.
4. Monitoring post-treatment: Progesterone assay and ultrasound at 14 and 28 days post-treatment; confirm uterine clearance before next breeding.

3.4 Breeding Soundness Evaluation (BSE) — Bull / Stallion

1. Physical examination: Body condition score, locomotion, penile/preputial integrity, scrotal circumference (≥34 cm in mature bulls), testicular symmetry and consistency.
2. Semen collection: Electroejaculation or AV collection.
3. Semen evaluation:
   • Motility: ≥30% progressively motile (Society for Theriogenology minimum).
   • Morphology: ≥70% morphologically normal sperm.
4. Libido and mating ability assessment (arena test with a restrained female in estrus).
5. Classification algorithm:
   • Meets all criteria → SPB.
   • One criterion marginal/borderline → Deferred (re-evaluate in 60 days — one spermatogenic cycle).
   • Major abnormality (azoospermia, testicular hypoplasia, penile deviation, infectious lesion) → USB.
6. Additional diagnostics if deferred: Testicular biopsy, hormone panel (FSH, LH, testosterone), culture for Campylobacter fetus subspecies venerealis, Tritrichomonas foetus (bulls).

3.5 Equine Subfertility — Mare

1. Reproductive history review: Previous pregnancies, embryo loss episodes, vulvar conformation, prior reproductive surgeries.
2. Examine timing relative to seasonal cycle: Transition period (anovulatory) vs. physiological breeding season (Feb–Oct in Northern Hemisphere). Do not treat anovulatory mares as pathologically infertile.
3. Physical examination: Caslick's score (vulvar conformation), perineal body integrity, uterine culture and cytology (endometrial cytology: >2% PMN = endometritis).
4. Endometrial biopsy (Kenney-Doig classification):
   • Grade I: Normal — expected foaling rate >80%.
   • Grade IIa: Mild changes — 50–80% foaling rate.
   • Grade IIb: Moderate fibrosis — 10–50% foaling rate.
   • Grade III: Severe irreversible fibrosis — <10% foaling rate → consider embryo transfer from this mare as recipient disqualification.
5. Persistent mating-induced endometritis (PMIE): Uterine lavage with saline (2L) 4–6 hours post-breeding + oxytocin (20 IU IV) to promote uterine clearance.
6. Ovulation synchronization: Deslorelin acetate (1.8 mg SQ) or hCG (2500 IU IV) when dominant follicle ≥35 mm; AI or natural service within 24–48 hours.
7. Early embryonic loss: Progesterone supplementation (altrenogest 0.044 mg/kg daily PO) if progesterone <4 ng/mL after Day 5 post-ovulation.

3.6 Assisted Reproductive Technologies (ART) — Decision Framework

• Evaluate ovarian response (antral follicle count, AFC) prior to FSH administration.
• AFC <10: Poor response anticipated — consider OPU-IVF instead.
• AFC ≥15: Good superovulation candidate — FSH twice-daily decreasing doses ×4 days.

4. Clinical Decision Trees: Summary Diagrams

4.1 Dystocia Decision Tree

Cow/Mare in labor >30 min active straining
         │
         ▼
    Vaginal exam
         │
    ┌────┴────────────────┐
    │                     │
Torsion?               No torsion
    │                     │
    ▼                     ▼
Roll/Surgery      Assess presentation
                         │
              ┌──────────┴───────────┐
              │                      │
        Normal position         Malposition
              │                      │
         Traction OK?          Mutation possible?
              │                      │
         Yes → ADEL          Yes → Correct + Traction
              │                      │
         Delivered           No → Fetotomy/C-section

4.2 Pyometra Decision Tree

Uterine fluid + Purulent discharge
         │
         ▼
CL present? (Ultrasound)
    │              │
   YES            NO (open cervix)
    │              │
PGF₂α           Culture + Lavage
    │              │
Monitor 14d     Monitor regression
    │
Resolved? → Rebreed at next cycle
No → Repeat PGF₂α or consider OHE

5. Ethical and Economic Dimensions of Clinical Decision Making

• Animal welfare: Prolonged dystocia intervention beyond humane limits mandates fetotomy or C-section, not escalating traction force. The Two-Person Rule limits obstetric traction to protect the dam.
• Culling decisions: Repeat breeder cows with Grade IIb/III endometrial biopsy and irreversible cervical stenosis may have better economic return from culling than continued treatment.
• Antimicrobial stewardship: Routine intrauterine antibiotic infusion is increasingly discouraged in favor of prostaglandin-based protocols and uterine lavage to minimize resistance selection pressure.
• ART justification: OPU-IVF and ICSI are high-cost, specialized procedures warranted only when genetic value justifies the investment or when alternative methods have failed.
• Client communication: Informed consent documentation before surgical procedures (C-section, OHE) and clear prognostic communication for poor-prognosis cases (Grade III endometrium, closed pyometra with systemic illness) are non-negotiable components of clinical decision making.

6. Documentation and Record-Keeping as a Decision Tool

• Reproductive herd records (Inter-calving interval, days open, conception rate per service, abortion incidence) enable population-level decisions: when to adopt a synchronization program, when to test for Neospora caninum or BVDV.
• Individual case records must capture: date of service/AI, semen lot/bull ID, progesterone values, ultrasound findings, treatments administered with doses, and follow-up dates.
• Decision auditing: Post-season reproductive performance analysis (pregnancy rate, early embryonic death rate, abortion rate) allows retrospective validation of protocol efficacy — a hallmark of evidence-based theriogenology practice.

7. Conclusion

References

1. Noakes DE, Parkinson TJ, England GCW. Veterinary Reproduction and Obstetrics, 10th ed. Saunders Elsevier, 2019.
2. Youngquist RS, Threlfall WR. Current Therapy in Large Animal Theriogenology, 2nd ed. Saunders Elsevier, 2007.
3. Society for Theriogenology. Minimum Standards for Semen Evaluation and Breeding Soundness Examination of Bulls. Available at: https://www.theriogenology.org
4. Kenney RM, Doig PA. Equine Endometrial Biopsy. In: Current Therapy in Equine Medicine. 1986.
5. Beef Reproduction Task Force. Applied Reproductive Strategies in Beef Cattle. 2020 Proceedings. Available at: Applied Reproductive Strategies in Beef Cattle
6. Barański W, et al. "Reproductive management in dairy herds." Clinical Theriogenology. Available at: Reproductive Management in Dairy Herds
7. University of Pennsylvania School of Veterinary Medicine — New Bolton Center. Reproduction Clinical Services. Available at: UPenn Vet Reproduction Services